Appili Therapeutics Inc. (OTCMKTS:APLIF) (TSX:APLI) Stock Falls 6% In a Week: Company Reports Q3 Earnings
Appili Therapeutics Inc. (OTCMKTS:APLIF) (TSX: APLI) is down 6% in a week. The company has announced its fiscal Q3 2022…
Read More »